join us
sign in
support us
contact us
Second Anakoinosis Meeting - Re-Establishing Apoptosis Competence via Communicative Reprogramming: A Novel Anticancer Therapy
19 - 20 April 2018
Registration deadline
22 March 2018
Abstract submission deadline
22 March 2018


 We are happy to announce the ‘Second Anakoinosis Meeting’ - Re-Establishing Apoptosis Competence via Communicative Reprogramming: A Novel Anticancer Therapym (Pathophysiology - Preclinic - Clinic) to be held in Rome at Villa Mondragone, on April 19th - 20th, 2018.

The Conference will focus on most recent trends and developments for re-establishing a therapeutically relevant novel communicative behavior of tumor tissue, hosting organ and organism by re-modulating gene expression, thus recovering differentiation and apoptosis competence leading to cancer control independently of cytotoxic therapies.

Our goal is gathering together clinicians and basic biologists to create a transversal and multidisciplinary scientific network, merging the basic knowledge on tissue homeostatic regulation with clinical applications in biomodulatory anticancer therapies. We hope you may join us in this challenging task.




Basic scientists in the cell, development, and molecular biology field interested in epigenetic, tissue homeostasis and gene expression regulation regarding cancer

genesis, progression and therapy; pharmacologists; Immunologists; clinical oncologists.

Participation is open and free for audience and speakers; all participants must register within March 22 (late comers please contact the organizing Committee).ù

For speakers: colleagues who want to propose for an oral communication should additionally upload an abstract (deadline March 22), which will be evaluated by the scientific Committee; acceptance will be communicated within March 30th. Speakers may also choose the Conference dinner option (35€).

The Conference is linked to the ‘Frontiers in Pharmacology’ Research Topic “ANAKOINOSIS - Re-Establishing Apoptosis Competence via Communicative Reprogramming:

A Novel Anticancer Therapy (Pathophysiology - Preclinic - Clinic)” that is already posted online and open for submissions. The papers, which can be of many different

article types (Original Research, Methods, Hypothesis & Theory, etc.), will be peer reviewed and published in Frontiers in Pharmacology (IF 4.4).

We invite all the interested colleagues to submit a contribution to the Research Topic, independently of participation to the Second Anakoinosis Meeting, by linking to the

Research Topic site and following instructions.

For any questions, please contact us

phone +49-941-9445541 or +39-06-72594218,

email at or

We hope to see you soon in Villa Mondragone!

Best regards,


Prof. Dr. Albrecht Reichle, University Hospital Regensburg, Department of Internal Medicine III, Hematology/Oncology, 93042 Regensburg (Germany) Facsimile:

Prof. Dr. Lina Ghibelli, University of Roma Tor Vergata, Department of Biology, Roma (Italy)


Conference Program

Confirmed Speakers